Your browser doesn't support javascript.
loading
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.
Reddy, Krishna P; Shebl, Fatma M; Foote, Julia H A; Harling, Guy; Scott, Justine A; Panella, Christopher; Fitzmaurice, Kieran P; Flanagan, Clare; Hyle, Emily P; Neilan, Anne M; Mohareb, Amir M; Bekker, Linda-Gail; Lessells, Richard J; Ciaranello, Andrea L; Wood, Robin; Losina, Elena; Freedberg, Kenneth A; Kazemian, Pooyan; Siedner, Mark J.
Afiliación
  • Reddy KP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: kpreddy@mgh.harvard.edu.
  • Shebl FM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Foote JHA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Harling G; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA; Harvard Center for Population and Development Studies, Harvard T H Chan School of Public Health, Boston, MA, USA; Africa Health Research Institute, Durban, South Africa; Institute for Global Health, University Col
  • Scott JA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Panella C; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Fitzmaurice KP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Flanagan C; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Hyle EP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard University Center for AIDS Research, Cambridge, MA, USA.
  • Neilan AM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Division of General Academic Pediatrics, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Mohareb AM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Bekker LG; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa.
  • Lessells RJ; KwaZulu-Natal Research Innovation and Sequencing, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Ciaranello AL; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard University Center for AIDS Research, Cambridge, MA, USA.
  • Wood R; Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa.
  • Losina E; Harvard Medical School, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA; Orthopaedic and Arthritis Center for Outcomes Research and Policy and Innovation eValuation in Orthopaedic Treatments (PIVOT) Center, Department of Orthopaedic Surgery, B
  • Freedberg KA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Depa
  • Kazemian P; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Siedner MJ; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Africa Health Research Institute, Durban, South Africa.
Lancet Glob Health ; 9(2): e120-e129, 2021 02.
Article en En | MEDLINE | ID: mdl-33188729

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 1_doencas_nao_transmissiveis / 1_financiamento_saude / 2_muertes_prematuras_enfermedades_notrasmisibles / 2_muertes_prevenibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases / 7_environmental_health / 7_non_communicable_diseases / 7_nutrition Asunto principal: Salud Pública / Epidemias / COVID-19 Tipo de estudio: Health_economic_evaluation / Prognostic_studies Aspecto: Determinantes_sociais_saude Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Middle aged / Newborn País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 1_doencas_nao_transmissiveis / 1_financiamento_saude / 2_muertes_prematuras_enfermedades_notrasmisibles / 2_muertes_prevenibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases / 7_environmental_health / 7_non_communicable_diseases / 7_nutrition Asunto principal: Salud Pública / Epidemias / COVID-19 Tipo de estudio: Health_economic_evaluation / Prognostic_studies Aspecto: Determinantes_sociais_saude Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Middle aged / Newborn País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2021 Tipo del documento: Article
...